Lutronic Announces FDA Clearance of its SPECTRA VRM SERIES III Q-Switched Nd:YAG Laser System for Treating a Broad Spectrum of Dermatological and Aesthetic Conditions
Lutronic, one of the world’s leading developers and manufacturers of medical laser systems, announced today that it has received FDA clearance to market its Spectra VRM III. This dual pulse QSwitched Nd:Yag laser is the feature rich successor to the Spectra VRM II. The laser produces 4 wavelengths (1064 nm, 532 nm, 585 nm, 650 nm) in Qswitched nanosecond pulse. It is specifically designed to treat a wide array of dermatological and aesthetic conditions including, dermal and epidermal pigmented lesions, multicolor tattoos, melasma, and active acne. It further enables laser toning, and non-ablative photo-acoustic skin rejuvenation techniques.
The laser incorporates a dual pulse mode, which enables it to produce very short and quasi-long microsecond pulses. There are numerous advantages which result from the unique pulse characteristics not found in other lasers including extreme high peak power and a flat-top beam profile. “The VRM III is extremely effective for the treatment of melasma. I have been achieving near 100% clearance on melasma treatment therapy. This is very impressive because melasma is traditionally thought to be treatment resistant. Further, the VRM has also been highly effective for the treatment of Post-Inflammatory Hyperpigmentation that may result as adverse side affects from other lasers or IPL treatments” explains Dr. Sooil Chun, the clinical professor of Yonsei University. The company states that further scientific works are being conducted for this treatment in an effort to collect additional empirical data for peer reviewed studies.
As tattoo removal is becoming one of the fastest growing treatment groups, the 4 wavelength option offered by the VRM III laser enables treatment of a wide range of colors. The laser’s flat-top beam profile provides increased patient comfort and reduced pinpoint bleeding, resulting in fewer side effects and significantly faster healing. The fine control of the 532 nm wavelength feature assures that epidermal lesions are treated with measurably less potential for PIH.
With an installed base of over 2000 VRM series units globally, the new VRM III is proving to be the workhorse system of choice for laser clinics around the world.
About Lutronic Lutronic Corporation is a leading developer and manufacturer of medical laser systems serving the dermatological and plastic surgery communities. With distribution in over 40 countries and over a decade of award-winning technology design that includes its Spectra line of products and its unparalleled MOSAIC fractional systems, the company is committed to delivering innovative, highly effective, and painless laser solutions.
Lutronic continues to offer impressive customer service and support to physicians and other qualified practitioners across the U.S. and globally. To learn more about the eCO2, please visit www.lutronic.com.
Director, Marketing & Public Relations Lutronic, Inc.
Phone: 609 275-1565 x302
888 588-7644 Fax: 609 275-3800